A host of amicus briefs critical of the Federal Circuit's "machine-transformation" test for patent eligibility, as recently set forth in the court's en banc Bilski decision, will be filed this week with the US Supreme Court. Some of these briefs reflect concerns of biotechnology industry, particulary with respect to patentability of diagnostics and personalized medicine, I will post some of these briefs as they become available to me. Briefs supporting affirmance of Bilski will be filed later this summer.
In the meantime, those interested in some of my thoughts on the subject might want to check out an article I recently posted on SSRN, you should be able to access it at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1424493&download=yes, but if you have problems please let me know and I will get you a copy.
Subscribe to:
Post Comments (Atom)
Posts
4 comments:
nice blog and have lots of stuff here.........
http://biotechnolo.blogspot.com
Hi Chris,
Sorry to meet you this way. I was puzzled by your characterization of my Chapter 7 as regarding an "anti-commons" argument. It makes no such claim. Rather I make an original philosophical/ontological argument about the nature of "commons" in general, and conclude that DNA fits what I call "commons by necessity." Did you read that chapter, or were you too frustrated with you legal disagreements with my position? I understand if you were, you clearly have some passionate feelings about your position, as many advocates do.
all my best,
David
Could you e-mail me a copy of your paper? Please send to thuy.nguyen@rogers.com.
I enjoy your blog. Thank you for the paper and your insights.
I just couldn't leave your website before telling you that I truly enjoyed the top quality info you present to your visitors? Will be back again frequently to check up on new posts.
Post a Comment